Radiotherapy Combined with Enhanced Immunotherapy for NSCLC

被引：0
|
作者：
Miao, C. [1 ]
Yuan, S. [1 ]
机构：
[1] Univ Sci & Technol China, Prov Hosp, Hefei, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
NSCLC; Tislelizumab; Radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA05.06
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [21] Vascular normalization in immunotherapy: A promising mechanisms combined with radiotherapy
    Liu, Zijing
    Zhao, Qin
    Zheng, Zhuangzhuang
    Liu, Shiyu
    Meng, Lingbin
    Dong, Lihua
    Jiang, Xin
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [22] Design Considerations for Clinical Trials of Radiotherapy Combined with Immunotherapy
    Sezen, Duygu
    Welsh, James
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2023, 38 (01): : 120 - 123
  • [23] Radiotherapy combined with immunotherapy: present status and future perspectives
    Lambin, P.
    Rekers, N.
    Yaromina, A.
    Dubois, L.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S276 - S277
  • [24] Toxicity of combined stereotactic Radiotherapy and targeted Chemotherapy or Immunotherapy
    Heitmann, J.
    Kroeze, S. G. C.
    Blanck, O.
    Stera, S.
    Kahl, K. H.
    Gerum, S.
    Combs, S. E.
    Kaul, D.
    Claes, A.
    Schymalla, M.
    Grosu, A. -L
    Eckert, F.
    Lohaus, F.
    Abbasi-Senger, N.
    Henke, G.
    Szuecs, M.
    Geier, M.
    Sundahl, N.
    Buergy, D.
    Shankar, S.
    Guckenberger, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S156 - S157
  • [25] Timing of radiotherapy affects outcomes of patients with metastatic NSCLC who receive immunotherapy
    Li, S.
    Inampudi, J. V.
    Koshiya, H. R.
    Patel, J. M.
    Wiest, N. E.
    Pai, T. S.
    Butts, E. B.
    McKinley, B. J.
    Wang, J.
    Correia, G. Sacchi De Camargo
    Mosalem, O. M.
    Manochakian, R.
    Zhao, Y.
    Lou, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S69 - S69
  • [26] Combined model of frameshift mutations and TMB in predicting response to immunotherapy in NSCLC
    Zhou, H.
    Liu, J.
    Zhang, Y.
    Fang, W.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [27] Anlotinib combined with sintilimab versus chemotherapy combined with immunotherapy in perioperative NSCLC: A phase II study
    Chu, T.
    Li, J.
    Huang, K.
    Pan, S.
    Qian, J.
    Lu, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1618 - S1618
  • [28] Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity
    Gao, Zhiru
    Zhao, Qian
    Xu, Yiyue
    Wang, Linlin
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [29] Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors
    Ji, Xiaoqin
    Jiang, Wanrong
    Wang, Jiasheng
    Zhou, Bin
    Ding, Wei
    Liu, Shuling
    Huang, Hua
    Chen, Guanhua
    Sun, Xiangdong
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [30] Combined chemotherapy, radiotherapy, and immunotherapy for pancreatic carcinoma -: A case report
    Busch, M
    Wilkowski, R
    Schaffer, M
    Dühmke, E
    ADVANCES IN THERAPY, 2000, 17 (03) : 133 - 139
12345